9 Reasons to Buy Pfizer in 2018 and 1 Big One Not To Post author:Sam Post published:December 21, 2017 Post category:BioPharma Pfizer may be the surprise strong-growth stock for next year. Source: BioSpace You Might Also Like Insulet, Mayo Clinic Jump in On $35 Million Series C Funding Round June 27, 2017 Phosphagenics Limited Signs Development Agreement For TPM/Oxymorphone Patch In Japan August 21, 2017 Amgen Faces Setback as Osteoporosis Drug is Linked to Serious Heart Side Effects May 21, 2017
